Anticancer activity of thymoquinone against breast cancer cells: Mechanisms of action and delivery approaches.
暂无分享,去创建一个
M. Darroudi | M. Kabiri | Zeinab Sayyahi | T. Farkhondeh | S. Samarghandian | M. Karami | H. Shabani | P. Moulavi | Mahsa Mardasi | Shahrad Soghala | S. Baghini | Jalili Kolour | Mohammad Amir Parvin | Ali Chopani
[1] A. A. El-Shehawy,et al. Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches , 2023, BMC Complementary Medicine and Therapies.
[2] Yayin Fang,et al. Thymoquinone effect on the Dictyostelium discoideum model correlates with functional roles for glutathione S-transferases in eukaryotic proliferation, chemotaxis, and development , 2023, PloS one.
[3] Khaled S. Allemailem,et al. Experimental and Theoretical Insights on Chemopreventive Effect of the Liposomal Thymoquinone Against Benzo[a]pyrene-Induced Lung Cancer in Swiss Albino Mice , 2022, Journal of inflammation research.
[4] Mohammed A. Alsahli,et al. Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer , 2022, Pharmaceutics.
[5] S. Hamid,et al. Formulation, Characterization and Cytotoxicity Effects of Novel Thymoquinone-PLGA-PF68 Nanoparticles , 2021, International journal of molecular sciences.
[6] T. Gratieri,et al. Polymeric nanocapsules: a review on design and production methods for pharmaceutical purpose. , 2021, Methods.
[7] H. Gali-Muhtasib,et al. Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells , 2021, World journal of clinical oncology.
[8] D. Cordato,et al. The role of thymoquinone, a major constituent of Nigella sativa, in the treatment of inflammatory and infectious diseases , 2021, Clinical and experimental pharmacology & physiology.
[9] Junjiang Fu,et al. Synergistic Role of Thymoquinone on Anticancer Activity of 5-fluorouracil in Triple-Negative Breast Cancer Cells. , 2021, Anti-cancer agents in medicinal chemistry.
[10] S. Mousa,et al. Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity. , 2021, Nanomedicine.
[11] M. Asif,et al. Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments , 2021, Drug delivery.
[12] K. Wadher,et al. Development of topical thymoquinone loaded polymer–lipid hybrid vesicular gel: in-vitro and ex-vivo evaluation , 2021, Journal of liposome research.
[13] Jie Liang,et al. Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development , 2021, Cancer biology & medicine.
[14] Khaled S. Allemailem,et al. Safety and Therapeutic Efficacy of Thymoquinone-Loaded Liposomes against Drug-Sensitive and Drug-Resistant Acinetobacter baumannii , 2021, Pharmaceutics.
[15] R. Khan,et al. Thymoquinone-Loaded Nanocarriers for Healthcare Applications , 2021 .
[16] H. A. Al-Jamal,et al. Thymoquinone, as a Novel Therapeutic Candidate of Cancers , 2021, Pharmaceuticals.
[17] R. Rahbarghazi,et al. Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells , 2021, BMC Complementary Medicine and Therapies.
[18] A. Sultan,et al. Abstract PS19-28: Thymoquinone and tamoxifen co-treatment synergistically inhibit proliferation, invasion and induce apoptosis in human breast cancer cell lines in vitro and in vivo , 2021 .
[19] Rizwanullah,et al. Effect of Chitosan Coating on PLGA Nanoparticles for Oral Delivery of Thymoquinone: In Vitro, Ex Vivo, and Cancer Cell Line Assessments , 2020, Coatings.
[20] K. Pal,et al. Guar gum micro-vehicle mediated delivery strategy and synergistic activity of thymoquinone and piperine: An in vitro study on bacterial and hepatocellular carcinoma cells , 2020 .
[21] H. Gali-Muhtasib,et al. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization , 2020, International journal of nanomedicine.
[22] Mohammed S. Alqahtani,et al. Development, Characterization Optimization, and Assessment of Curcumin-Loaded Bioactive Self-Nanoemulsifying Formulations and Their Inhibitory Effects on Human Breast Cancer MCF-7 Cells , 2020, Pharmaceutics.
[23] D. Chowdhury,et al. Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use , 2020, International journal of nanomedicine.
[24] M. Shakibaei,et al. An Overview of the Role of Adipokines in Cardiometabolic Diseases , 2020, Molecules.
[25] Hana M. Gashlan,et al. Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells , 2020, Scientific Reports.
[26] Khalid Rehman Hakeem,et al. An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties , 2020, Journal of Herbal Medicine.
[27] C. Zhong,et al. Thymoquinone Selectively Induces Hepatocellular Carcinoma Cell Apoptosis in Synergism With Clinical Therapeutics and Dependence of p53 Status , 2020, Frontiers in Pharmacology.
[28] Suhair Sunoqrot,et al. Development of a Thymoquinone Polymeric Anticancer Nanomedicine through Optimization of Polymer Molecular Weight and Nanoparticle Architecture , 2020, Pharmaceutics.
[29] Yihan Yao,et al. Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance , 2020, Frontiers in Molecular Biosciences.
[30] O. Ahmed,et al. Thymoquinone Loaded Zein Nanoparticles Improves the Cytotoxicity against Breast Cancer Cells , 2020 .
[31] S. Mousa,et al. Thymoquinone and Costunolide Induce Extensive Apoptosis of Senescent Colon and Senescent Breast Cancer Cells , 2020 .
[32] M. Hasnain,et al. Lipid based nano carriers for cancer and tumor treatment. , 2020, Current pharmaceutical design.
[33] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[34] R. Thangam,et al. Synergetic effects of thymoquinone-loaded porous PVPylated Fe3O4 nanostructures for efficient pH-dependent drug release and anticancer potential against triple-negative cancer cells , 2020, Nanoscale advances.
[35] N. Alhakamy,et al. Preparation and Characterization of Chitosan Coated PLGA Nanoparticles of Resveratrol: Improved Stability, Antioxidant and Apoptotic Activities in H1299 Lung Cancer Cells , 2020, Coatings.
[36] R. Censi,et al. Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities , 2020, Nanomaterials.
[37] K. Pal. Facile Synthesis of Natural Therapeutics Encapsulated Biopolymeric Okra Mucilage Nanoparticles as Dual ameliorative agent , 2020 .
[38] D. Chellappan,et al. Nanocarriers: more than tour de force for thymoquinone , 2020, Expert opinion on drug delivery.
[39] M. Mesbah,et al. Stability study of thymoquinone, carvacrol and thymol using HPLC-UV and LC-ESI-MS , 2020, Acta pharmaceutica.
[40] M. Rahaie,et al. Thymoquinone-loaded ethosome with breast cancer potential: optimization, in vitro and biological assessment , 2020, Journal of Nanostructure in Chemistry.
[41] M. Raish,et al. Gender effect on the pharmacokinetics of thymoquinone: Preclinical investigation and in silico modeling in male and female rats , 2020, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[42] R. P,et al. In vitro studies to analyze the stability and bioavailability of thymoquinone encapsulated in the developed nanocarrier , 2020, Journal of Dispersion Science and Technology.
[43] P. Ranjekar,et al. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice , 2020, Frontiers in Pharmacology.
[44] S. Akhter,et al. Co-encapsulation of Docetaxel and Thymoquinone in mPEG-DSPE-Vitamin E TPGS-Lipid nanocapsules for breast cancer therapy: Formulation Optimization and Implications on cellular and in vivo toxicity. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[45] A. M. Al-Abd,et al. Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism , 2020, Molecules.
[46] S. Mousa,et al. Senescent Colon and Breast Cancer Cells Induced by Doxorubicin Exhibit Enhanced Sensitivity to Curcumin, Caffeine, and Thymoquinone , 2020, Integrative cancer therapies.
[47] A. Sattar,et al. Pharmacokinetics of thymoquinone in layer chickens following oral and intravenous administration. , 2019, Journal of veterinary pharmacology and therapeutics.
[48] W. Alshaer,et al. Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel , 2019, Heliyon.
[49] F. Ahmad,et al. Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies. , 2019, Colloids and surfaces. B, Biointerfaces.
[50] Junjiang Fu,et al. Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics. , 2019, Drug discovery today.
[51] Rajesh Singh,et al. Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway , 2019, Cancers.
[52] N. Nordin,et al. Ultrastructural Changes and Antitumor Effects of Doxorubicin/Thymoquinone-Loaded CaCO3 Nanoparticles on Breast Cancer Cell Line , 2019, Front. Oncol..
[53] H. Abdelrazek,et al. Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[54] A. M. Al-Abd,et al. Abstract 2995: Thymoquinone attenuates breast cancer cell resistance to paclitaxel via targeting tumor associated stem cell population , 2019, Experimental and Molecular Therapeutics.
[55] Ki‐Hyun Kim,et al. Antidiabetic activity enhancement in streptozotocin + nicotinamide–induced diabetic rats through combinational polymeric nanoformulation , 2019, International journal of nanomedicine.
[56] Ebrahim M Yimer,et al. Nigella sativa L. (Black Cumin): A Promising Natural Remedy for Wide Range of Illnesses , 2019, Evidence-based complementary and alternative medicine : eCAM.
[57] M. Mirzaei,et al. Evaluation of Carum-loaded Niosomes on Breast Cancer Cells:Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay , 2019, Scientific Reports.
[58] Arif Khan,et al. Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells , 2019, Asian Pacific journal of cancer prevention : APJCP.
[59] I. Badea,et al. Polymeric Nanoparticles in Gene Therapy: New Avenues of Design and Optimization for Delivery Applications , 2019, Polymers.
[60] S. Hamid,et al. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells. , 2018, Advances in experimental medicine and biology.
[61] M. R. Mozafari,et al. Enhanced efficacy and bioavailability of thymoquinone using nanoliposomal dosage form , 2018, Journal of Drug Delivery Science and Technology.
[62] G. Karimi,et al. An overview of in vivo toxicological profile of thymoquinone , 2018, Toxin Reviews.
[63] S. Mousa,et al. Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases , 2018, Nutrients.
[64] A. M. Al-Abd,et al. Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities , 2018, Scientific Reports.
[65] S. Jacob,et al. Cyclodextrin complexes: Perspective from drug delivery and formulation , 2018, Drug development research.
[66] Chau Dang,et al. Overview of Breast Cancer Therapy. , 2018, PET clinics.
[67] Wei Keat Ng,et al. Thymoquinone loaded in nanostructured lipid carrier showed enhanced anticancer activity in 4T1 tumor-bearing mice. , 2018, Nanomedicine.
[68] Bo Liu,et al. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis , 2018, Genes & diseases.
[69] T. Farkhondeh,et al. The Neuroprotective Effects of Thymoquinone: A Review , 2018, Dose-response : a publication of International Hormesis Society.
[70] Jingyuan Wen,et al. Nanostructured Lipid Carriers , 2018 .
[71] I. Pathan,et al. Curcumin loaded ethosomes for transdermal application: Formulation, optimization, in-vitro and in-vivo study , 2018 .
[72] D. Choi,et al. Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders , 2018, Oxidative medicine and cellular longevity.
[73] P. Maiti,et al. Controlled drug delivery vehicles for cancer treatment and their performance , 2018, Signal Transduction and Targeted Therapy.
[74] H. Gali-Muhtasib,et al. Thymoquinone-based nanotechnology for cancer therapy: promises and challenges. , 2018, Drug discovery today.
[75] E. Wasan,et al. An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery , 2017, Pharmaceutics.
[76] M. Akram,et al. Awareness and current knowledge of breast cancer , 2017, Biological Research.
[77] Chandragouda R. Patil,et al. Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin , 2017, Front. Pharmacol..
[78] T. Webster,et al. Elastic liposomes as novel carriers: recent advances in drug delivery , 2017, International journal of nanomedicine.
[79] Wamidh H. Talib. Regressions of Breast Carcinoma Syngraft Following Treatment with Piperine in Combination with Thymoquinone , 2017, Scientia pharmaceutica.
[80] M. Raish,et al. Oral bioavailability enhancement and hepatoprotective effects of thymoquinone by self-nanoemulsifying drug delivery system. , 2017, Materials science & engineering. C, Materials for biological applications.
[81] M. I. Khan,et al. Hybrid Nano-carriers for Potential Drug Delivery , 2017 .
[82] Xiangshan Chen,et al. Self-assembled nanocapsules in water: a molecular mechanistic study. , 2017, Physical chemistry chemical physics : PCCP.
[83] Naser Karimi,et al. Application of Various Types of Liposomes in Drug Delivery Systems , 2017, Advanced pharmaceutical bulletin.
[84] M. Boskabady,et al. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review. , 2016, Journal of ethnopharmacology.
[85] J. Ferdous,et al. Thymoquinone is Knocking at the Door of Clinical Trial , 2016 .
[86] T. Viitala,et al. Enhancement of Bioavailability and Pharmacodynamic Effects of Thymoquinone Via Nanostructured Lipid Carrier (NLC) Formulation , 2016, AAPS PharmSciTech.
[87] Ranjita Shegokar,et al. Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications , 2016, Expert opinion on drug delivery.
[88] Banu Iskender,et al. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer , 2016, Tumor Biology.
[89] N. Sharma,et al. Exploring versatile applications of cyclodextrins: an overview , 2016, Drug delivery.
[90] Michael R Hamblin,et al. Chitin and Chitosan: Production and Application of Versatile Biomedical Nanomaterials. , 2016, International journal of advanced research.
[91] Banu Iskender,et al. Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway? , 2016, Tumor Biology.
[92] P. Fisher,et al. Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold Niosomes. , 2015, Molecular pharmaceutics.
[93] Ajaz Ahmad,et al. Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model , 2015, European Journal of Drug Metabolism and Pharmacokinetics.
[94] M. Raish,et al. Effects of Thymoquinone on the Pharmacokinetics and Pharmacodynamics of Glibenclamide in a Rat Model , 2015, Natural product communications.
[95] S. Mirhafez,et al. Thymoquinone Ameliorates Acute Renal Failure in Gentamicin-Treated Adult Male Rats , 2015, Pharmacology.
[96] M. Hashemi,et al. The Comparison of Anticancer Activity of Thymoquinone and Nanothymoquinone on Human Breast Adenocarcinoma , 2015, Iranian journal of pharmaceutical research : IJPR.
[97] A. Alzohairy,et al. Health-promoting value and food applications of black cumin essential oil: an overview , 2015, Journal of Food Science and Technology.
[98] M. Mandal,et al. Thymoquinone Restores Radiation‐Induced TGF‐β Expression and Abrogates EMT in Chemoradiotherapy of Breast Cancer Cells , 2015, Journal of cellular physiology.
[99] Xiaoyang Xu,et al. Cancer Nanomedicine: From Targeted Delivery to Combination Therapy , 2015, Trends in molecular medicine.
[100] K. Tikoo,et al. Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy , 2015, Journal of Nanoparticle Research.
[101] Wei Keat Ng,et al. Thymoquinone-Loaded Nanostructured Lipid Carrier Exhibited Cytotoxicity towards Breast Cancer Cell Lines (MDA-MB-231 and MCF-7) and Cervical Cancer Cell Lines (HeLa and SiHa) , 2015, BioMed research international.
[102] Seon-Mi Yu,et al. The thymoquinone-induced production of reactive oxygen species promotes dedifferentiation through the ERK pathway and inflammation through the p38 and PI3K pathways in rabbit articular chondrocytes , 2014, International journal of molecular medicine.
[103] S. Samarghandian,et al. Preventive effect of safranal against oxidative damage in aged male rat brain , 2014, Experimental animals.
[104] Dongming Qi,et al. Recent advances in the preparation of hybrid nanoparticles in miniemulsions. , 2014, Advances in colloid and interface science.
[105] S. Aly,et al. Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways , 2014, Evidence-based complementary and alternative medicine : eCAM.
[106] Huixia Lv,et al. Aqueous Solubility and Degradation Kinetics of the Phytochemical Anticancer Thymoquinone; Probing the Effects of Solvents, pH and Light , 2014, Molecules.
[107] A. A. Martens,et al. The multiple facets of drug resistance: one history, different approaches , 2014, Journal of experimental & clinical cancer research : CR.
[108] Rupesh Dudhe,et al. Nanoemulsion: an advanced mode of drug delivery system , 2014, 3 Biotech.
[109] V. Saini,et al. Formulation and Characterization of Drug Loaded Nonionic Surfactant Vesicles (Niosomes) for Oral Bioavailability Enhancement , 2014, TheScientificWorldJournal.
[110] R. Abu-Dahab,et al. Preparation, characterization and antiproliferative activity of thymoquinone-beta-cyclodextrin self assembling nanoparticles. , 2013, Die Pharmazie.
[111] Marjaneh Motaghed,et al. Thymoquinone regulates gene expression levels in the estrogen metabolic and interferon pathways in MCF7 breast cancer cells , 2013, International journal of molecular medicine.
[112] F. Khanum,et al. Thymoquinone-loaded PLGA nanoparticles: antioxidant and anti-microbial properties , 2013 .
[113] G. Sethi,et al. Thymoquinone Inhibits Tumor Growth and Induces Apoptosis in a Breast Cancer Xenograft Mouse Model: The Role of p38 MAPK and ROS , 2013, PloS one.
[114] Ç. Şakalar,et al. Pronounced transcriptional regulation of apoptotic and TNF–NF-kappa-B signaling genes during the course of thymoquinone mediated apoptosis in HeLa cells , 2013, Molecular and Cellular Biochemistry.
[115] Marjaneh Motaghed,et al. Cellular responses with thymoquinone treatment in human breast cancer cell line MCF-7 , 2013, Pharmacognosy research.
[116] T. Collares,et al. Developments in the use of nanocapsules in oncology , 2013, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[117] Doman Kim,et al. Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava , 2013, Bioorganic & Medicinal Chemistry.
[118] I. Suzuki,et al. Thymoquinone protects cultured rat primary neurons against amyloid β-induced neurotoxicity. , 2013, Biochemical and biophysical research communications.
[119] P. Fisher,et al. Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer , 2013, PloS one.
[120] S. Aly,et al. The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy. , 2013, International journal of clinical and experimental medicine.
[121] W. Khalil,et al. Evaluation of the protective effect of Nigella sativa extract and its primary active component thymoquinone against DMBA-induced breast cancer in female rats , 2013, Archives of medical science : AMS.
[122] Ajaz Ahmad,et al. HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY OF THYMOQUINONE IN RABBIT PLASMA AND ITS APPLICATION TO PHARMACOKINETICS , 2013 .
[123] K. Allison,et al. Computer aided detection , 2000, Breast Cancer Research.
[124] G. Mustafa,et al. Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study , 2012, International journal of nanomedicine.
[125] R. Abu-Dahab,et al. Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer , 2012, Drug delivery.
[126] A. Pichette,et al. ANTIOXIDANT, ANTI‐INFLAMMATORY, ANTICANCER AND ANTIBACTERIAL ACTIVITIES OF EXTRACTS FROM NIGELLA SATIVA (BLACK CUMIN) PLANT PARTS , 2012 .
[127] F. Tanfani,et al. Characterization of thymoquinone binding to human α₁-acid glycoprotein. , 2012, Journal of pharmaceutical sciences.
[128] G. Colditz,et al. Family history and risk of breast cancer: nurses’ health study , 2012, Breast Cancer Research and Treatment.
[129] Anders Axelsson,et al. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review. , 2011, International journal of pharmaceutics.
[130] F Atyabi,et al. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents , 2011, International journal of nanomedicine.
[131] Jun Jie Wang,et al. Recent advances of chitosan nanoparticles as drug carriers , 2011, International journal of nanomedicine.
[132] R. Schobert,et al. Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin , 2011, Cancer Chemotherapy and Pharmacology.
[133] G. Wani,et al. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. , 2011, Mutation research.
[134] F. Tanfani,et al. Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[135] I. Warner,et al. Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles , 2010, Nanotechnology.
[136] G. Kulkarni,et al. Nanoemulsion: A new concept of delivery system , 2010 .
[137] Cui Tang,et al. Folate-mediated solid–liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol) , 2010, Drug development and industrial pharmacy.
[138] P. Eckl,et al. Antimutagenic effects of ethanolic extracts from selected Palestinian medicinal plants. , 2010, Journal of ethnopharmacology.
[139] R. Schneider-Stock,et al. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling , 2010, Apoptosis.
[140] F. Meng,et al. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. , 2009, Biomaterials.
[141] J. Benoit,et al. Lipid nanocapsules: a new platform for nanomedicine. , 2009, International journal of pharmaceutics.
[142] M. Nagi,et al. Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity , 2009, Phytotherapy research : PTR.
[143] Zhiwei Wang,et al. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. , 2009, Cancer research.
[144] A. Al-Amri,et al. PHASE I SAFETY AND CLINICAL ACTIVITY STUDY OF THYMOQUINONE IN PATIENTS WITH ADVANCED REFRACTORY MALIGNANT DISEASE , 2009 .
[145] Mingyao Liu,et al. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways , 2008, Molecular Cancer Therapeutics.
[146] B. Aggarwal,et al. Targeting Nuclear Factor-κB Activation Pathway by Thymoquinone: Role in Suppression of Antiapoptotic Gene Products and Enhancement of Apoptosis , 2008, Molecular Cancer Research.
[147] M. Menon,et al. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. , 2007, Cancer research.
[148] Y. N. Park,et al. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. , 2007, International journal of molecular medicine.
[149] G. Lupidi,et al. Nonenzymatic reduction of thymoquinone in physiological conditions , 2007, Free radical research.
[150] V. Pillay,et al. Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres. , 2005, International journal of pharmaceutics.
[151] R. Goldbohm,et al. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease , 2001, The Lancet.
[152] R. Löbenberg,et al. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[153] J. Bolton,et al. Role of quinones in toxicology. , 2000, Chemical research in toxicology.
[154] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[155] G. Shadab,et al. Low doses of thymoquinone protect isolated human blood cells from TiO2 nanoparticles induced oxidative stress, hemolysis, cytotoxicity, DNA damage and collapse of mitochondrial activity , 2021 .
[156] Soha Gomaa,et al. Combination treatment of thymoquinone-loaded gold nanoparticles and cisplatin potentiates anti-tumor activity and immunomodulatory effects in breast cancer model - , 2018 .
[157] Prabhanjan S. Giram,et al. Ethosome: A Novel Drug Carrier , 2013 .
[158] P. Eckl,et al. In vitro toxicological properties of thymoquinone. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[159] S. Haque,et al. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome , 2008, International journal of diabetes in developing countries.
[160] Aamir Ahmad,et al. From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond. , 2008, Cancer therapy.
[161] R. Schneider-Stock,et al. The medicinal potential of black seed (Nigella sativa) and its components , 2006 .
[162] P. Dudrick,et al. In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. , 2003, International journal of oncology.
[163] Jingliang Cheng,et al. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition. , 2015, Oncotarget.